Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in GILD — Gilead Sciences, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$813,577,293
-$110,228,526 QoQ
Shares Held
6,439,586
-2.8% QoQ
Ownership
0.519%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#30
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$2,147,780
PutShares
17,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. GILD ranks #6 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,646,119 $5,572,694,974
2 JNJ
Johnson & Johnson
 17,374,433 $4,412,584,747
3 AMGN
Amgen Inc
 7,235,462 $2,620,105,497
4 ABBV
AbbVie Inc.
 9,017,580 $2,269,183,828
5 MRK
Merck & Co., Inc.
 11,658,434 $1,498,108,767
6 GILD
Gilead Sciences, Inc.
This page 		6,439,586 $813,577,293
7 PFE
Pfizer Inc
 20,193,675 $486,263,691
8 BMY
Bristol Myers Squibb Co
 6,321,643 $364,253,067

All Filings in GILD

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $813,577,293 6,439,586
2026-06-30 $2,147,780 17,000
2026-03-31 $2,369,290 17,000
2026-03-31 $923,805,819 6,628,441
2025-12-31 $816,119,737 6,649,175
2025-12-31 $1,902,470 15,500
2025-09-30 $716,173,554 6,452,014
2025-09-30 $1,942,500 17,500
2025-06-30 $715,464,951 6,453,188
2025-06-30 $1,940,225 17,500
2025-03-31 $732,025,784 6,533,028
2025-03-31 $1,960,875 17,500
2024-12-31 $629,484,182 6,814,812
2024-09-30 $603,016,514 7,192,468
2024-06-30 $501,411,825 7,308,145
2024-03-31 $517,674,082 7,067,223
2024-03-31 $278,350 3,800
2023-12-31 $576,997,124 7,122,542
2023-12-31 $388,848 4,800
2023-09-30 $527,071,827 7,033,251
2023-09-30 $359,712 4,800
2023-06-30 $369,936 4,800
2023-06-30 $556,974,020 7,226,859
2023-03-31 $630,697,614 7,601,514
2022-12-31 $703,257,442 8,191,700
2022-09-30 $526,149,750 8,528,931
2022-06-30 $527,643,472 8,536,539
2022-03-31 $5,945,000 100,000
2022-03-31 $518,720,212 8,725,319
2022-03-31 $178,350 3,000
2021-12-31 $532,766,796 7,337,375
2021-09-30 $642,115,400 9,192,776
2021-06-30 $642,768,365 9,334,423
2021-03-31 $361,928 5,600
2021-03-31 $587,706,115 9,093,395
2020-12-31 $546,081,347 9,373,178
2020-12-31 $111,000 161,100
2020-09-30 $4,000 3,500
2020-09-30 $546,742,374 8,652,356
2020-09-30 $30,000 300,000
2020-06-30 $537,218,697 6,982,307
2020-06-30 $1,000 1,500
2020-03-31 $507,000 101,200
2020-03-31 $702,852,473 9,401,451
2020-03-31 $316,000 97,400

Report a Problem

Category
Description
Email (optional, for follow-up)